Cargando…

Relapsed diffuse large B-cell lymphoma present different genomic profiles between early and late relapses

Despite major advances in first-line treatment, a significant proportion of patients with diffuse large B-cell lymphoma (DLBCL) will experience treatment failure. Prognosis is particularly poor for relapses occurring less than one year after the end of first-line treatment (early relapses/ER) compar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Broséus, Julien, Chen, Gaili, Hergalant, Sébastien, Ramstein, Gérard, Mounier, Nicolas, Guéant, Jean-Louis, Feugier, Pierre, Gisselbrecht, Christian, Thieblemont, Catherine, Houlgatte, Rémi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356640/ https://www.ncbi.nlm.nih.gov/pubmed/27276707 http://dx.doi.org/10.18632/oncotarget.9793

Ejemplares similares

VEGF(121), is predictor for survival in activated B-cell-like diffuse large B-cell lymphoma and is related to an immune response gene signature conserved in cancers
por: Broséus, Julien, et al.
Publicado: (2017)

Microenvironment Remodeling and Subsequent Clinical Implications in Diffuse Large B-Cell Histologic Variant of Richter Syndrome
por: Augé, Hélène, et al.
Publicado: (2020)

How I manage patients with relapsed/refractory diffuse large B cell lymphoma
por: Gisselbrecht, Christian, et al.
Publicado: (2018)

Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis
por: Broséus, Julien, et al.
Publicado: (2023)

Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies
por: Cabannes‐Hamy, Aurélie, et al.
Publicado: (2018)

Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysis
por: Thieblemont, Catherine, et al.
Publicado: (2023)

Do we have to exclude all relapsed diffuse large B‐cell lymphoma patients not in complete remission from autologous stem cell transplant?
por: Gisselbrecht, Christian, et al.
Publicado: (2022)

MicroRNAs miR-16 and miR-519 control meningioma cell proliferation via overlapping transcriptomic programs shared with the RNA-binding protein HuR
por: Hergalant, Sébastien, et al.
Publicado: (2023)

Clinicopathological and genetic features of limited-stage diffuse large B-cell lymphoma with late relapse: targeted sequencing analysis of gene alterations in the initial and late relapsed tumors
por: Suzuki, Tomotaka, et al.
Publicado: (2020)

Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas
por: Gaudio, Francesco, et al.
Publicado: (2011)

The European Medicines Agency Review of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
por: Delgado, Julio, et al.
Publicado: (2021)

Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma
por: Hazane Leroyer, Esther, et al.
Publicado: (2022)

Management of relapsed-refractory diffuse large B cell lymphoma
por: Raut, Lalit S., et al.
Publicado: (2014)

Diffuse Large B Cell Lymphoma with Extensive Cutaneous Relapse
por: Malkan, Umit Yavuz, et al.
Publicado: (2015)

Mutational Evolution in Relapsed Diffuse Large B-Cell Lymphoma
por: Nijland, Marcel, et al.
Publicado: (2018)

Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation
por: Pagliuca, Simona, et al.
Publicado: (2023)

Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation
por: Pagliuca, Simona, et al.
Publicado: (2023)

Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cells
por: Galtier, Jean, et al.
Publicado: (2022)

Late relapses in Hodgkin lymphoma – should we search for the needle in the haystack?
por: El‐Galaly, Tarec Christoffer, et al.
Publicado: (2022)

Relapse in stage I(E) diffuse large B‐cell lymphoma
por: Nijland, Marcel, et al.
Publicado: (2017)

Novel Therapies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
por: Harris, Leonard Jeff, et al.
Publicado: (2020)

Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
por: Sehn, Laurie H., et al.
Publicado: (2020)

Tafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma
por: Salles, Gilles, et al.
Publicado: (2021)

Neurolymphomatosis as a manifestation of relapsed diffuse large B‐cell lymphoma
por: Okamura‐Shiki, Ikue, et al.
Publicado: (2022)

Reconstructing clonal evolution in relapsed and non-relapsed Burkitt lymphoma
por: Reutter, Katrin, et al.
Publicado: (2020)

P1217: INTRATHECAL METHOTREXATE PROPHYLAXIS AND CENTRAL NERVOUS SYSTEM RELAPSE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH INTENSIFIED R-ACVBP STRATEGY
por: Renaud, L., et al.
Publicado: (2022)

Late Central Nervous System Relapse in a Patient with Maxillary Sinus Lymphoma
por: Kewan, Tariq, et al.
Publicado: (2018)

Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective
por: Sureda, Anna, et al.
Publicado: (2020)

Intraocular lymphoma as relapse after chemotherapy for primary breast diffuse large B-cell lymphoma
por: Matsuo, Toshihiko, et al.
Publicado: (2018)

Lymphoma relapse presenting as neurolymphomatosis
por: Pham, My, et al.
Publicado: (2016)

Relapsed/Refractory Hodgkin Lymphoma
por: Sheikh, Semira, et al.
Publicado: (2018)

Presentation of Diffuse Large B-Cell Lymphoma Relapse as a Penile Mass
por: Öneç, Birgül, et al.
Publicado: (2016)

Relapsed Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type
por: Wu, Shaohua, et al.
Publicado: (2017)

A diffuse large B cell lymphoma emerging with breast cancer relapse
por: Karismaz, Abdulkadir, et al.
Publicado: (2018)

Efficacy of salvage radiotherapy for relapsed/refractory diffuse large B-cell lymphoma
por: Wang, Shu-Bei, et al.
Publicado: (2019)

Cytomegalovirus lymphadenitis mimicking a relapsed diffuse large B‐cell lymphoma
por: Delaye, Matthieu, et al.
Publicado: (2022)

The clinical challenge of relapsed diffuse large B-cell lymphoma with disseminated infection
por: Goh, Suek Chern, et al.
Publicado: (2023)

Lenalidomide in Diffuse Large B-Cell Lymphoma
por: Thieblemont, Catherine, et al.
Publicado: (2012)

MADGene: retrieval and processing of gene identifier lists for the analysis of heterogeneous microarray datasets
por: Baron, Daniel, et al.
Publicado: (2011)

Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma
por: Armand, Philippe, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kbuo8hbe1nomdq7bavvqh8p6l6